Blog post

2 x Life Science Hype Cycles

By Michael Shanler | July 29, 2017 | 0 Comments

wearablestransformationSupply ChainSecurityScienceRegulatoryR&DProduct DevelopmentpharmaceuticalpharmaNoFManufacturinglaboratoryLaboratoriesITIoTIoLTInternet of ThingsInternet of Everythinginnovationhype cycleGartnerePROEngineeringEDCeClinicalDigital MarketingdigitalCTMSComplianceCloudClinical DevelopmentCIOData and Analytics StrategiesIT Cost OptimizationMobile and Endpoint TechnologiesTechnology and Emerging Trends

While the spring rains drenched the northeastern U.S. and parts of Europe, Jeff, Steve, and I were hard at work authoring, arranging, writing, reviewing,  re-reviewing, re-re-reviewing our content.  After countless cups of coffee, our 2 x hype cycles that cover the life science industry are finally published.  These docs are relevant for CIOs, IT and business leaders that run organizations at pharma, biotech, med-device, and CROs.  Roles representing other highly-regulated science-based product development industries (e.g. cosmetics, nutriceuticals, food & beverage) may also find these hype cycles interesting.

Keep in mind the relationship between these two documents-

~80 technologies are covered in these 2 x hype cycles.   Since “life science” is a bit of a moving target and we see disruption happening on the fringe with health care industry segments, it might pay to become familiar with these other HC docs, as  well:

Of course, there are specialty non-industry specific hype cycles, too.    For example:

 

Comments are closed